Reliability, validity, and responsiveness of the short form 36 (SF-36) health survey questionnaire in patients with Graves’ disease

1. Geffken GR, Ward HE, Staab JP, Carmichael SL, Evans DL. Psychiatric morbidity in endocrine disorders. Psychiatr Clin North Am. 1998; 21:473-89.10.1016/S0193-953X(05)70017-4Open DOISearch in Google Scholar

2. Kathol RG, Delahunt JW. The relationship of anxiety and depression to symptoms of hyperthyroidism using operational criteria. Gen Hosp Psychiatry. 1986; 8:23-8.10.1016/0163-8343(86)90060-5Open DOISearch in Google Scholar

3. Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Grave’s disease. Gen Hosp Psychiatry. 1988; 10:49-55.10.1016/0163-8343(88)90084-9Open DOISearch in Google Scholar

4. Fahrenfort JJ, Wilterdink AM, van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology. 2000; 25:201-11.10.1016/S0306-4530(99)00050-5Open DOISearch in Google Scholar

5. Scheffer C, Heckmann C, Mijic T, Rudorff KH. Chronic distress syndrome in patients with Graves’ disease. Med Klin. 2004; 99:578-84.10.1007/s00063-004-1089-315490073Open DOISearch in Google Scholar

6. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G. Impaired healthrelated quality of life in Graves’ disease. A prospective study. Eur J Endocrinol. 2004; 151:549-55.10.1530/eje.0.151054915538931Open DOISearch in Google Scholar

7. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res. 2004; 13:45-54.10.1023/B:QURE.0000015315.35184.66Open DOISearch in Google Scholar

8. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, healthrelated quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006; 37:133-9.10.1016/j.arcmed.2005.05.00816314199Open DOISearch in Google Scholar

9. Razvi S, Ingoc IE, McMillan CV, Weaver JU. Health status in patients with sub-clinical hypothyroidism. Eur J Endocrinol. 2005; 152:713-17.10.1530/eje.1.0190715879356Open DOISearch in Google Scholar

10. Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalization. J Epidemiol Community Health. 2003; 57:259-63.10.1136/jech.57.4.259173242512646540Open DOISearch in Google Scholar

11. Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Results from Whitehall II study. BMJ. 1997; 315:1273-9.10.1136/bmj.315.7118.1273Open DOISearch in Google Scholar

12. Hemingway H, Nicholson A, Stafford M, Roberts R, Marmot M. The impact of socioeconomic status on health functioning as assessed by the SF-36 questionnaire: the Whitehall II study. Am J Public Health. 1997; 87:1484-90.10.2105/AJPH.87.9.1484Open DOISearch in Google Scholar

13. McHorney CA, Ware JE, Rachel Lu JF, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36): III. Test of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32:40-6610.1097/00005650-199401000-00004Open DOISearch in Google Scholar

14. Jolliffe IT. Principal Component Analysis. New York: Springer; 1986. p. 62-70.10.1007/978-1-4757-1904-8Search in Google Scholar

15. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis. 1987; 40:171-8.10.1016/0021-9681(87)90069-5Open DOISearch in Google Scholar

16. Ware JE, Gandek B. IQOLA Project Group. The SF-36 Health Survey: Development and use in mental health research and the IQOLA Project. Int J Ment Health. 1994; 23:49-73.10.1080/00207411.1994.11449283Open DOISearch in Google Scholar

17. Hobson P, Bhowmick B, Meara J. Use of the SF-36 questionnaire in cerebrovascular disease. Stroke. 1997; 28:464-5.Search in Google Scholar

18. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, et al. The development and validation of a dysphasia-specific quality-of-life questionnaire for patients with head and neck cancer. The Anderson dysphasia inventory. Arch Otolaryngol Head Neck Surg. 2001; 127:870-6.Search in Google Scholar

19. Jenkinson C, Coulter A, Wright L. Short form 36 (SF-36) health survey questionnaire: Normative data for adults of working age. Br Med J. 1993; 306:1437-40.10.1136/bmj.306.6890.1437Open DOISearch in Google Scholar

20. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36). Med Care. 1992; 30:473-83.10.1097/00005650-199206000-00002Open DOISearch in Google Scholar

21. Pinar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Re. 2005; 14:259-64.10.1007/s11136-004-2393-3Search in Google Scholar

22. Failde I, Ramos I. Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000; 53:359-65.10.1016/S0895-4356(99)00175-4Open DOISearch in Google Scholar

23. Koh ET, Leong KP, Tsou IY, Lim VH, Pong LY, Chong SY, et al. The reliability, validity and sensitivity of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis. Rheumatology. 2006; 45:1023-8.10.1093/rheumatology/kel05116495318Open DOISearch in Google Scholar

24. Riley ED, Bangsberg DR, Perry S, Clark RA, Moss AR, Wu AW. Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Qual Life Res. 2003; 12:1051-8.10.1023/A:1026166021386Open DOISearch in Google Scholar

25. van der Heijden PG, van Buuren S, Fekkes M, Radder J, Verrips E. Unidimensionality and reliability under Mokken scaling of the Dutch language version of the SF-36. Qual Life Res. 2003; 12:189-98.10.1023/A:1022269315437Search in Google Scholar

26. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation in internal reliability and face validity of the SF-36 questionnaire in women presenting with menorrhagia. Qual Health Care. 1996; 5:9-12.10.1136/qshc.5.1.9105534810157276Open DOISearch in Google Scholar

27. Bunevicius R, Velickiene D, Prange AJ Jr. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves’ disease. Gen Hosp Psychiatry. 2005; 27:133-9.10.1016/j.genhosppsych.2004.10.00215763125Open DOISearch in Google Scholar

28. Liu J, Shu Q, Wang JZ. Assessing the quality of life of patients with systemic lupus erythematosus using SF-36. Chin J Public Health (Chin). 2004; 11:1383-4.Search in Google Scholar

29. McHorney CA, Ware JE, Raczek AE. The MOS 36-items Short-form Health Survey (SF-36) II. Psychometric and clinical test of validity in measuringphysical and mental health constructs. Med Care. 1993; 31:247-63.10.1097/00005650-199303000-000068450681Open DOISearch in Google Scholar

30. Ruta DA, Hurst NP, Kind P, Hunter M, Stubings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol. 1998; 37:425-36.10.1093/rheumatology/37.4.4259619895Open DOISearch in Google Scholar

31. Abraham-Nordling M, Wallin G, Lundell G, Törring O. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves’ disease. Eur J Endocrinol. 2007; 2:173-9.10.1530/eje.1.0233617287406Open DOISearch in Google Scholar

32. Abraham-Nordling M, Törring O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J, Wallin G. Graves’ disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005; 11:1279-86.10.1089/thy.2005.15.127916356093Open DOISearch in Google Scholar

33. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol. 2005; 152:1-9. 10.1530/eje.1.0180915762182Open DOISearch in Google Scholar